Great Point Partners-backed VitaLink Research Acquires Comprehensive Clinical Trials

LongueVue Capital portfolio company Pinnacle Clinical Research completes acquisitions of five clinical research sites

June 18, 2024

Healthcare Services

LongueVue Capital’s portfolio company Pinnacle Clinical Research has completed investments/acquisitions of five clinical research sites: Kerwin Medical Center, The Cognitive and Research Center of New Jersey, Bellaire Clinical Research, Palmetto Clinical Research – Low Country, and Dallas Research Institute. The additions broaden Pinnacle’s U.S. geographic footprint and expand therapeutic-area expertise, including central nervous system focus for Alzheimer’s disease indications via Kerwin Medical Center and CRCNJ.

Kohlberg Acquires Majority Stake in Worldwide Clinical Trials

August 7, 2023

Healthcare Services

An affiliate of Kohlberg & Company agreed to acquire a majority stake in Worldwide Clinical Trials, a global contract research organization (CRO) headquartered in Research Triangle Park, North Carolina. The transaction is a recapitalization in which prior investor TJC, L.P. retains a meaningful minority equity stake; terms were not disclosed. Kohlberg will partner with Worldwide's management (Matt Jennings to become chairman) to support continued growth of the company's clinical trial and bioanalytical capabilities.

Headlands Research Acquires Clinvest Research

May 4, 2023

Healthcare Services

Headlands Research, a multinational clinical trial site network, has acquired Clinvest Research, a Springfield, Missouri-based clinical research site that has conducted over 600 trials since 1996. The deal expands Headlands' chronic pain and endocrinology capabilities and increases participant access for trials in the United States.

Velocity Clinical Research Acquires VitaLink Research and National Research Institute

September 22, 2021

Healthcare Services

Durham-based Velocity Clinical Research acquired two multi-site clinical research companies—VitaLink Research (six sites in South Carolina) and National Research Institute (five sites in the Los Angeles area)—adding 11 sites to its network. The deal expands Velocity's therapeutic reach and patient recruitment capabilities, creating one of the largest fully integrated site management organizations in the U.S.

Therapeutic Research Center (TRC) Acquires CriticalPoint and Clinical IQ

April 8, 2020

Healthcare Services

Therapeutic Research Center (TRC), a portfolio company of Levine Leichtman Capital Partners, has acquired CriticalPoint, LLC and Clinical IQ, LLC to expand its sterile compounding training, consulting and compliance capabilities. The deal augments TRC's education platform and strengthens its domain expertise in compounding, aseptic processing and USP compliance.

Veristat Acquires The Clinical Trial Company Ltd (TCTC Group)

January 6, 2020

Healthcare Services

Veristat, a full-service CRO based in Southborough, Massachusetts, has acquired The Clinical Trial Company Ltd (TCTC Group), a Europe-headquartered contract research organization. The deal expands Veristat's European footprint and adds TCTC's expertise in gene and cell therapy, CNS and orphan disease clinical trials to Veristat's service offering.